We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
–
AUM
$384M
AUM Growth
+$42.1M
Cap. Flow
+$6.1M
Cap. Flow %
1.59%
Top 10 Hldgs %
33.42%
Holding
402
New
39
Increased
71
Reduced
55
Closed
20

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$3.64M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.27M
3
GILD icon
Gilead Sciences
GILD
+$1.9M
4
SBCF icon
Seacoast Banking Corp of Florida
SBCF
+$1.75M
5
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$1.53M

Top Sells

Rank Stock Value
1
IAU icon
iShares Gold Trust
IAU
+$1.7M
2
NVDA icon
NVIDIA
NVDA
+$477K
3
ET icon
Energy Transfer Partners
ET
+$408K
4
IBM icon
IBM
IBM
+$398K
5
MCD icon
McDonald's
MCD
+$344K

Sector Composition

Rank Sector Weight
1 Technology 25.59%
2 Healthcare 14.79%
3 Consumer Staples 13.71%
4 Miscellaneous 12.81%
5 Financials 12.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WELL icon
101
Welltower
WELL
$172B
$409K 0.11%
6,330
-4
-0.1% -$243
SCHB icon
102
Schwab US Broad Market ETF
SCHB
$44.7B
$405K 0.11%
26,682
– –
CL icon
103
Colgate-Palmolive
CL
$72.3B
$399K 0.1%
4,671
+1,710
+58% +$141K
DD icon
104
DuPont de Nemours
DD
$18.5B
$390K 0.1%
4,374
– –
BFAM icon
105
Bright Horizons
BFAM
$3.64B
$372K 0.1%
2,150
– –
IFF icon
106
International Flavors & Fragrances
IFF
$22.4B
$370K 0.1%
3,400
– –
IBB icon
107
iShares Biotechnology ETF
IBB
$10.5B
$353K 0.09%
2,330
– –
ABBV icon
108
AbbVie
ABBV
$451B
$344K 0.09%
3,213
+1
+0% +$96
CVGW
109
DELISTED
Calavo Growers
CVGW
$344K 0.09%
+4,960
New +$350K
CAT icon
110
Caterpillar
CAT
$368B
$332K 0.09%
1,826
+95
+5% +$16.1K
TJX icon
111
TJX Companies
TJX
$149B
$325K 0.08%
4,759
+2,056
+76% +$125K
DOW icon
112
Dow Inc
DOW
$22B
$320K 0.08%
5,767
– –
QCOM icon
113
Qualcomm
QCOM
$175B
$307K 0.08%
2,012
– –
PSX icon
114
Phillips 66
PSX
$97.4B
$296K 0.08%
4,234
– –
KNSL icon
115
Kinsale Capital Group
KNSL
$8.67B
$290K 0.08%
1,450
– –
APD icon
116
Air Products & Chemicals
APD
$68.6B
$260K 0.07%
950
-100
-10% -$28.2K
COP icon
117
ConocoPhillips
COP
$157B
$252K 0.07%
6,297
– –
PSF icon
118
Cohen & Steers Select Preferred & Income Fund
PSF
$234M
$246K 0.06%
+8,765
New +$232K
MSM icon
119
MSC Industrial Direct
MSM
$6.66B
$245K 0.06%
2,900
– –
CINF icon
120
Cincinnati Financial
CINF
$26.4B
$238K 0.06%
2,720
+1,795
+194% +$143K
CSCO icon
121
Cisco
CSCO
$433B
$230K 0.06%
5,150
+1,132
+28% +$46.5K
UNP icon
122
Union Pacific
UNP
$183B
$222K 0.06%
1,067
+689
+182% +$138K
DIS icon
123
Walt Disney
DIS
$187B
$221K 0.06%
1,221
+644
+112% +$92.4K
NKE icon
124
Nike
NKE
$58.7B
$208K 0.05%
1,468
+4
+0.3% +$530
COST icon
125
Costco
COST
$419B
$198K 0.05%
525
+300
+133% +$112K
3 4
5
6 7

Similar funds

BPM
Bowling Portfolio Management Cincinnati, Ohio $364M AUM 7.07% 1-Year Est. Return
S
Surevest Los Angeles, California $368M AUM 13.7% 1-Year Est. Return
ACM
Axar Capital Management New York $304M AUM 38.78% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return
AW
ACG Wealth Atlanta, Georgia $437M AUM 11.28% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
SMG
Spectrum Management Group Indianapolis, Indiana $460M AUM 10.37% 1-Year Est. Return

American Research & Management Company's Q4 2020 Portfolio in Review

As of Q4 2020, American Research & Management Company held 402 positions worth $384M, up 12% from $342M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

American Research & Management Company's Q4 2020 filing shows 39 new, 71 increased, 55 reduced and 20 closed positions. Its largest new stake was Vertex Pharmaceuticals: 9,888 shares worth $2.34M. The largest sale was iShares Gold Trust, an estimated $1.7M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Staples.

  • American Research & Management Company's largest Q4 2020 buy was Vertex Pharmaceuticals: 9,888 shares worth $2.34M.
  • American Research & Management Company added most to Franco-Nevada in Q4 2020, an estimated $3.64M increase.
  • American Research & Management Company's biggest Q4 2020 reduction was iShares Gold Trust, cutting an estimated $1.7M.
  • American Research & Management Company fully exited iShares Russell Mid-Cap Growth ETF in Q4 2020, selling an estimated $25K.
  • American Research & Management Company's ten largest holdings make up 33% of its $384M portfolio in Q4 2020.
  • American Research & Management Company opened 39 new positions and closed 20 in Q4 2020.
  • American Research & Management Company's portfolio value rose 12% quarter-over-quarter to $384M.

Based on American Research & Management Company's 13F filing for Q4 2020, filed 28 Jan 2021.